Navigation Links
Unilife to Participate in Two Investor Conferences

YORK, Pa., Sept. 6, 2011 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS), today announced that its Chief Executive Officer, Alan Shortall, will be presenting at two upcoming investor conferences taking place in New York.  

  • On Monday, September 12, Mr. Shortall will present at the Rodman and Renshaw Annual Global Investment Conference in New York at 11:40 a.m. EDT.
  • On Wednesday, September 14, Mr. Shortall will present at the Morgan Stanley Global Healthcare Conference in New York at 3:20 p.m. EDT.

  • Each of the conference presentations will be broadcast over the Internet as a "live" listen only Webcast. To listen, please go to: An archive of each event will also be available for those unable to listen live.

    About Unilife CorporationUnilife Corporation (NASDAQ: UNIS / ASX: UNS) is a U.S.-based developer, manufacturer and supplier of advanced drug delivery systems with state-of-the-art facilities in Pennsylvania. Established in 2002, Unilife works with pharmaceutical and biotechnology companies seeking innovative devices for use with their parenteral drugs and vaccines. Unilife has developed a broad, differentiated proprietary portfolio of its own injectable drug delivery products, including the Unifill® and Unitract® product lines of safety syringes with automatic, operator controlled needle retraction. Unifill represents the world's first prefilled syringe technology integrating safety within the primary drug container. The products are ideally positioned to help pharmaceutical companies maximize the lifecycle of their injectable drugs and enhance patient care. Unifill syringes, together with other devices that are part of the Unilife technology platform, can either be supplied to pharmaceutical customers ready for use, or customized to address the specific requirements of targeted novel drugs.  For more information on Unilife, please visit 

    Forward-Looking Statements This press release contains forward-looking statements. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements. These forward-looking statements are based on management's beliefs and assumptions and on information currently available to our management. Our management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We do not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in "Item 1A. Risk Factors" and elsewhere in our Annual Report on Form 10-K and those described from time to time in other reports which we file with the Securities and Exchange Commission. 

    General: UNIS-G Investor Contacts (US):Investor Contacts (Australia)Todd Fromer / Garth Russell

    Stuart Fine

    Jeff CarterKCSA Strategic Communications

    Carpe DM Inc

    Unilife CorporationPhone + 1 212-682-6300

    Phone + 1 908 469 1788

    Phone + 61 2 8346 6500

    SOURCE Unilife Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Unilife COO to Again Purchase More Than $250,000 in Company Shares
    2. Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011
    3. Unilife Develops Proprietary Range of Auto-Injectors for Patient Self-Administration of Injectable Drugs
    4. Unilife Develops Unifill® EZMix Multiple-Chamber Prefilled Syringes
    5. Unilife Signs $10 Million Equipment Financing Agreement
    6. Unilife Expands Management Team to Support Business Growth
    7. Unilife Starts Unifill Syringe Sales to Another Pharmaceutical Customer
    8. Unilife Successfully Completes Industrialization of Unifill Syringe
    9. Unilife Hosts White House Business Council Meeting
    10. Unilife to Present at the 2011 Jefferies Global Healthcare Conference in New York City
    11. Unilife to Present at the 2011 UBS Global Specialty Pharmaceuticals Conference in London
    Post Your Comments:
    (Date:12/1/2015)... VERONA, Virginia , 1 de diciembre ... líder en tecnología para cuchillas de precisión, ... un programa de identidad de marca. El ... en el diseño y la ingeniería de ... toda la diferencia". ...
    (Date:12/1/2015)... , Dec. 1, 2015 During the ... San Francisco, CA , Medinol ... the coronary marketplace. During a satellite symposium, "The ... Design to Minimize Restenosis", a renowned physician panel ... Medinol NIRxcell™ CoCr Coronary Stent System and the ...
    (Date:12/1/2015)... -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing ... that the company will present at the LD Micro Main ... Luxe Sunset Boulevard Hotel in Los Angeles, CA. ... will present on Thursday, December 3, at 9:00 am Pacific ... register at least 10 minutes prior to the start of ...
    Breaking Medicine Technology:
    (Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... Trustify is ... in Washington, DC, hosted by Becky’s Fund, an organization dedicated to ending domestic violence. ... and control back to battered victims and survivors of domestic violence. Trustify is also ...
    (Date:12/1/2015)... ... December 01, 2015 , ... On Tuesday ... to NASDAQ to educate the personnel on spinal decompression therapy and offer his ... a nonsurgical procedure. The benefits come from creating negative intradiscal pressure which is ...
    (Date:12/1/2015)... , ... December 01, 2015 , ... The Multiple System ... awareness and funds for Multiple System Atrophy (MSA) research, timed today to coincide with ... many things from patients including their ability to work and be productive, to do ...
    (Date:12/1/2015)... ... December 01, 2015 , ... The North American Meat ... that meat and poultry play in a healthy, balanced diet. , includes ... visitors can check their “meat IQ,” a section offering straight talk on controversies, ...
    (Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... World ... the Multi Jar, a container patent that allows for easier packing and organizing of ... US is worth $90 billion," says Scott Cooper, CEO and Creative Director of World ...
    Breaking Medicine News(10 mins):